日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

IL-5 CAR-T cell therapy induces effective remission in hypereosinophilic disorders

IL-5 CAR-T细胞疗法可有效缓解嗜酸性粒细胞增多症

Wu, Youqian; Zhang, Ruiqi; Sun, Beibei; Chen, Gaoying; Xu, Fang; Chen, Xinyi; Zeng, Jiayuan; Shen, Dan; Shi, Fan; Pan, Sheng; Yao, Bingpeng; Tang, Haoyu; Shao, Zhehua; Wu, Qian; Shao, Jiawei; Zhang, Chao; Wang, Dongrui; Hu, Yongxian; Ying, Songmin

Role of IL-5 in eosinophil-associated diseases and prospects for multi-target therapy

IL-5在嗜酸性粒细胞相关疾病中的作用及其多靶点治疗前景

Ou, Weiying; Wang, Yaoyao; Hou, Chengyu; Hou, Shujuan; Zhou, Yumei; Wang, Ji; Wang, Qi

Safety and efficacy of anti-IL-5 monoclonal antibodies as second-line therapy for chronic rhinosinusitis with nasal polyps: a meta-analysis

抗IL-5单克隆抗体作为慢性鼻窦炎伴鼻息肉二线疗法的安全性和有效性:一项荟萃分析

Liao, Huixiu; Qiu, Chaohong; Luo, Yingying; Chen, Jiaru; Qin, Congyu; Quan, Jieru; Liang, Weiming; Qin, Jiongying; Chen, Rui

Nanoencapsulation of Tomentosin-Rich Pulicaria crispa Fraction in MIL-53(Fe) Improves the Release Profile and In Vitro Anti-Colorectal Cancer Activity

将富含托门托辛的普利卡里亚卷叶提取物纳米封装于MIL-53(Fe)中,可改善其释放特性并增强其体外抗结直肠癌活性。

Abo-Elghiet, Fatma; Hakeem, George M; Mahmoud, Rehab; Ibrahim, Mona H; Nabil, Hamies B; Eldin, Zienab E; Abd Elhaleem, Maha B; Othman, Sarah I; Hassan, Nourhan; Elzayat, Emad M

Enhanced nanoencapsulation of gentamicin, ciprofloxacin, and lysozyme in chitosan-MIL-53 metal-organic frameworks for a synergistic activity against drug-resistant Salmonella from poultry and human origins

利用壳聚糖-MIL-53金属有机框架增强庆大霉素、环丙沙星和溶菌酶的纳米封装,以增强其对抗家禽和人类来源耐药沙门氏菌的协同活性

Ibrahim Mohamed, Fatma; Ibrahim, Mohamed Ali; Abdel-Latef, Gihan Kamal; Abdel-Rahim, Mohamed M; Shany, Salama A S; Mahmoud, Rehab; Mahgoub, Samar M; Othman, Sarah I; Aleem Abdel Aziz, Sahar Abdel

Red Mud-Based MIL-53(Fe) for the Efficient Adsorption of Methylene Blue: Preparation, Adsorption Performance, and Mechanism

赤泥基MIL-53(Fe)高效吸附亚甲基蓝:制备、吸附性能及机理

Wu, Shengqian; Wang, Xiaocheng; Ma, Yun; Ma, Lin

Clinical Remission in Severe T2-High Asthma in Real Life After Anti-IgE, Anti-IL-5 and Anti-IL5R: A Potential Role for CRP as a Biomarker

真实世界中重度T2高危哮喘患者接受抗IgE、抗IL-5和抗IL-5R治疗后临床缓解:CRP作为生物标志物的潜在作用

Vervier, Jeanne; Sabbe, Marie; Louis, France; Moermans, Catherine; Guissard, Françoise; Sanchez, Carole; Paulus, Virginie; Henket, Monique; Philippe, Genevieve; Beijnink, Casper W H; Bridevaux, Pierre-Olivier; Schleich, Florence; Louis, Renaud

Preliminary Effects of Benralizumab in an AML Cell Model with Promyelocytic Features Expressing IL-5R: An Exploratory Proof-of-Concept Study

贝那利珠单抗在表达IL-5R的具有早幼粒细胞特征的AML细胞模型中的初步疗效:一项探索性概念验证研究

Piazzetta, Giovanna Lucia; Di Agostino, Silvia; Lobello, Nadia; Aloisio, Annamaria; Di Vito, Anna; Bria, Jessica; Filardo, Andrea; Coscarella, Isabella; Preianò, Mariaimmacolata; Pelaia, Corrado; Lombardo, Nicola; Chiarella, Emanuela

Beyond BMI: visceral adiposity assessed by the lipid accumulation product index shows independent associations with IL-5 and TNF-β in older adults

除了BMI之外:通过脂质蓄积产物指数评估的内脏脂肪与老年人的IL-5和TNF-β存在独立关联

Mancinetti, Francesca; Bastiani, Patrizia; Alunno, Martina; Tecchio, Veronica; Scamosci, Michela; Cecchetti, Roberta; Mecocci, Patrizia; Boccardi, Virginia

Feasibility of a 50% Dosing Interval Extension of Anti-IL-5 Biologics in Patients with Severe Asthma in Clinical Remission: A Real-World Validation Study

在临床缓解期重度哮喘患者中,将抗IL-5生物制剂的给药间隔延长50%的可行性:一项真实世界验证研究

Vergles, Mirna; Salai, Grgur; Tudorić, Neven; Kovačević, Ivona; Kifer, Domagoj; Lalić, Kristina; Gomerčić Palčić, Marija; Vukić Dugac, Andrea